• About us
• Contact

Advertisement

Person › Details

Peer Nils Schröder (Basilea Pharmaceutica Ltd. (SIX: BSLN))

Schröder, Peer Nils (Basilea 201109 Head Public Relations + Corporate Communications)

 

	Organisation	Basilea Pharmaceutica Ltd. (SIX: BSLN)
	Group	Basilea (Group)
	Product	antibiotic
	Product 2	Toctino®

Record changed: 2018-03-01

Advertisement

More documents for Peer Nils Schröder

• [1] Basilea Pharmaceutica Ltd.. (2/23/18). "Press Release: Basilea Reports Clinical Phase 3 Study Start with Antibiotic Ceftobiprole in Skin Infections under BARDA Contract". Basel....
• [2] Basilea Pharmaceutica Ltd.. (1/10/18). "Press Release: Basilea Announces Completion of the License Agreement Extension with Pfizer for Antifungal Cresemba for China and Asia Pacific". Basel....
• [3] Basilea Pharmaceutica Ltd.. (7/20/17). "Press Release: Basilea Announces Completion of the License Agreement with Pfizer for Antifungal Cresemba for Europe, Russia, Turkey and Israel". Basel....
• [4] Basilea Pharmaceutica Ltd.. (4/21/17). "Press Release: Basilea Announces Agreement with FDA on Special Protocol Assessments for Antibiotic Ceftobiprole Phase 3 Clinical Studies in Bloodstream and Skin Infections". Basel....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.